Table 1.
Pharmacy | SEP2 | ||||||
Variable | n | % | n | % | OR | 95% CI | p-value |
Gender: | |||||||
Male | 118 | 88.72 | 160 | 82.05 | 1.72 | 0.90–3.30 | 0.102 |
Female | 15 | 11.28 | 35 | 17.95 | 1.0 | ||
Age: | |||||||
< 20 | 12 | 9.02 | 9 | 4.62 | 2.41 | 0.91–6.35 | 0.075 |
20–24 | 41 | 30.83 | 60 | 30.77 | 1.23 | 0.68–2.23 | 0.486 |
25–29 | 49 | 36.84 | 70 | 35.90 | 1.26 | 0.71–2.24 | 0.420 |
> 30 | 31 | 23.31 | 56 | 28.72 | 1.0 | ||
Ethnicity: | |||||||
Russian | 106 | 84.80 | 168 | 87.05 | 0.83 | 0.44–1.58 | 0.571 |
Estonian | 19 | 15.20 | 25 | 12.95 | 1.0 | ||
Marital status: | |||||||
Single | 96 | 72.73 | 156 | 80.83 | 0.63 | 0.37–1.07 | 0.087 |
Married or cohabiting | 36 | 27.27 | 37 | 19.17 | 1.0 | ||
Educational level: | |||||||
< 9 years | 72 | 54.55 | 100 | 51.28 | 0.72 | 0.17–2.97 | 0.650 |
10–12 years | 56 | 42.42 | 91 | 46.67 | 0.62 | 0.15–2.56 | 0.504 |
> 12 years | 4 | 3.03 | 4 | 2.05 | 1.0 | ||
Main source of income in last 6 months: | |||||||
Other | 52 | 39.10 | 101 | 51.79 | 0.60 | 0.38–0.93 | 0.024 |
Regular or temporary job | 81 | 60.90 | 94 | 48.21 | 1.0 | ||
Having health insurance: | |||||||
No | 65 | 50.00 | 120 | 61.54 | 1.0 | ||
Yes | 65 | 50.00 | 75 | 38.46 | 1.60 | 1.02–2.51 | 0.040 |
Duration of injection career: | |||||||
0–2 years | 22 | 16.54 | 11 | 5.70 | 3.74 | 1.65–8.51 | 0.002 |
3–5 years | 30 | 22.56 | 30 | 15.54 | 1.87 | 0.99–3.54 | 0.054 |
6–9 years | 42 | 31.58 | 79 | 40.93 | 0.99 | 0.58–1.71 | 0.986 |
> 10 years | 39 | 29.32 | 73 | 37.82 | 1.0 | ||
Frequency of injecting: | |||||||
Less than daily | 50 | 37.59 | 47 | 24.10 | 1.0 | ||
Daily | 83 | 62.41 | 148 | 75.90 | 0.53 | 0.33–0.85 | 0.009 |
Intensity of injecting per day: | |||||||
One | 33 | 24.81 | 22 | 11.34 | 1.0 | ||
More than one | 100 | 75.19 | 172 | 88.66 | 0.39 | 0.21–0.70 | 0.002 |
Main drug injected during last 6 months: | |||||||
Fentanyl | 98 | 74.24 | 166 | 85.13 | 0.50 | 0.29–0.88 | 0.015 |
Amphetamine | 71 | 53.38 | 98 | 50.26 | 1.13 | 0.72–1.76 | 0.578 |
Ever overdosed: | |||||||
No | 52 | 39.10 | 61 | 31.28 | 1.0 | ||
Yes | 81 | 60.90 | 134 | 68.72 | 0.71 | 0.45–1.12 | 0.144 |
Sharing syringes during last 6 months: | |||||||
No | 82 | 62.12 | 128 | 65.98 | 1.0 | ||
Yes | 50 | 37.88 | 66 | 34.02 | 1.18 | 0.75–1.87 | 0.475 |
Sharing paraphernalia during last 6 months: | |||||||
No | 102 | 76.69 | 153 | 79.27 | 1.0 | ||
Yes | 31 | 23.31 | 40 | 20.73 | 1.16 | 0.68–1.98 | 0.579 |
Ever shared needles with someone known to be HIV positive: | |||||||
No | 38 | 29.46 | 34 | 18.48 | 1.0 | ||
Yes | 91 | 70.54 | 150 | 81.52 | 0.54 | 0.32–0.92 | 0.024 |
Sharing needles with sexual partner during last 6 months: | |||||||
No | 30 | 60.00 | 45 | 67.16 | 1.0 | ||
Yes | 20 | 40.00 | 22 | 32.84 | 1.36 | 0.63–2.92 | 0.425 |
Number of sexual partners during last 12 months: | |||||||
None or one | 63 | 47.37 | 116 | 60.42 | 1.0 | ||
More than one | 70 | 52.63 | 76 | 39.58 | 1.70 | 1.08–2.65 | 0.020 |
Number of casual partners during last 6 months: | |||||||
None | 71 | 53.38 | 133 | 68.21 | 1.0 | ||
One or more | 62 | 46.62 | 62 | 31.79 | 1.87 | 1.19–2.95 | 0.007 |
Condom use with casual partner during last 6 months: | |||||||
Never | 12 | 19.35 | 11 | 17.19 | 1.0 | ||
Occasionally/Always | 50 | 80.65 | 53 | 82.81 | 0.86 | 0.35–2.14 | 0.753 |
Condom use with primary partner during last 6 months: | |||||||
Never | 32 | 48.48 | 45 | 47.37 | 1.0 | ||
Occasionally/Always | 34 | 51.52 | 50 | 52.63 | 0.96 | 0.51–1.79 | 0.889 |
Self-reported STI (syphilis, gonorrhea, chlamydia, genital herpes): | |||||||
No | 119 | 89.47 | 173 | 88.72 | 1.0 | ||
Yes | 14 | 10.53 | 22 | 11.28 | 0.93 | 0.46–1.88 | 0.830 |
Disease serostatus: | |||||||
HIV+ | 61 | 45.86 | 123 | 64.06 | 0.48 | 0.30–0.75 | 0.001 |
HCV+ | 117 | 87.97 | 190 | 98.96 | 0.08 | 0.02–0.34 | 0.001 |
Ever had HIV test: | |||||||
No | 22 | 16.54 | 25 | 12.89 | 1.0 | ||
Yes | 111 | 83.46 | 169 | 87.11 | 0.75 | 0.40–1.39 | 0.356 |
Ever received drug treatment: | |||||||
No | 82 | 61.65 | 115 | 58.97 | 1.0 | ||
Yes | 51 | 38.35 | 80 | 41.03 | 0.89 | 0.57–1.40 | 0.627 |
Ever been in prison: | |||||||
No | 57 | 42.86 | 75 | 38.46 | 1.0 | ||
Yes | 76 | 57.14 | 120 | 61.54 | 0.83 | 0.53–1.30 | 0.426 |
1Reference group SEP users.
2Includes Syringe Exchange Program outreach workers as the source of new and unused syringes.